Back to library

SS-31 (Elamipretide)

Human observational

Also known as: Elamipretide, MTP-131

LongevityMitochondrial disease (investigational)

Community-reported ranges are anecdotal and not clinically validated. Evidence grade shown reflects the strength of available human data. Not a prescription. Legal status varies by country and changes over time; verify locally.

Overview

A mitochondria-targeting peptide in clinical development for mitochondrial and cardiac disease. Investigational; not approved.

Mechanism

Binds cardiolipin in the inner mitochondrial membrane, aiming to stabilise energy production.

Evidence

Human observationalWhat does this mean?

Clinical trials conducted with mixed results; investigational, not approved.

Community-reported information

Investigational; used outside trials anecdotally. General information only.

General information only, not tailored to you and not a recommendation. Some regions withhold this entirely.

Half-life

Short.

Storage

Refrigerate.

Commonly reported side effects

  • Injection-site reactions
  • Generally tolerated in trials

Legal status by region

  • USInvestigational; not FDA-approved.

Legal status changes over time; verify locally before relying on this.